Futura Medical (LON:FUM) Stock Price Up 11.7% – Here’s Why

Futura Medical plc (LON:FUM)’s stock price traded up 11.7% during trading on Thursday. The company traded as high as GBX 0.23 and last traded at GBX 0.22. Approximately 17,144,963 shares changed hands during mid-day trading, an increase of 65% from the average session volume of 10,386,199 shares. The stock had previously closed at GBX 0.20.

Futura Medical Price Performance

The firm has a market cap of £1.28 million, a price-to-earnings ratio of -0.27 and a beta of 0.02. The firm’s fifty day moving average is GBX 0.33 and its 200-day moving average is GBX 0.64.

Futura Medical (LON:FUM) last issued its quarterly earnings results on Tuesday, September 1st. The company reported GBX (0.20) EPS for the quarter. Futura Medical had a negative net margin of 158.21% and a negative return on equity of 152.42%. As a group, equities research analysts anticipate that Futura Medical plc will post 2.8486672 EPS for the current year.

About Futura Medical

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.